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Abstract: The molecular mechanisms and signalling cascades that trigger the induction of group I metabotropic glutamate 
receptor (GI-mGluR)-dependent long-term depression (LTD) have been the subject of intensive investigation for nearly two 
decades. The generation of genetically modified animals has played a crucial role in elucidating the involvement of key 
molecules regulating the induction and maintenance of mGluR-LTD. In this review we will discuss the requirement of the 
newly discovered MAPKAPK-2 (MK2) and MAPKAPK-3 (MK3) signalling cascade in regulating GI-mGluR-LTD. Recently 
it has been shown that the absence of MK2 impaired the induction of GI-mGluR-dependent LTD, an effect that that is caused 
by reduced internalisation of AMPAR. As the MK2 cascade directly regulates tumour necrosis factor alpha (TNFα) production, 
this review will examine the evidence that the release of TNFα acts to regulate glutamate receptor expression and therefore may 
play a functional role in the impairment of GI-mGluR-dependent LTD and the cognitive deficits observed in MK2/3 double 
knockout animals. The strong links of increased TNFα production in both aging and neurodegenerative disease could implicate 
the action of MK2 in these processes.  
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1. Introduction 
 Synaptic plasticity in neurons is an activity 
dependent change in synaptic efficacy, which is believed to 
be an experimental correlate of learning and memory [1]. 
The two primary types of synaptic plasticity are long-term 
potentiation (LTP) an increase in synaptic transmission 
strength and long-term depression (LTD) a decrease in 
synaptic transmission strength [1,2]. In the hippocampus 
there are two principal types of LTD, one form of LTD is 
induced by activation of ionotropic N-methyl-D-aspartate 
receptors (NMDAR), known as NMDAR-dependent LTD. 
The other form of LTD is induced by the activation of group 
I-metabotropic glutamate receptors (GI-mGluR-LTD). The 
known molecular mechanisms underlying these two types of 
LTD have been extensively reviewed elsewhere [2,3]. GI-
mGluR-LTD can be induced either by the application of the 
group 1 selective agonist (R,S)-3,5-dihydroxyphenylglycine 
(DHPG) or by paired-pulse low frequency stimulation (PP-
LFS) in the hippocampus [2,3]. The induction of GI-mGluR-
LTD is dependent on the activation of p38 mitogen-activated 
protein kinase (MAPK) in the hippocampus [4,5]. The 
downstream effectors for the p38 action during synaptic 
plasticity were unknown until recent evidence discovered 
that p38 regulates GI-mGluR-LTD via the activation of the 
MAPK-activated protein kinases 2 and 3 (MAPKAPK-2 and 
MAPKAPK-3, also known as MK2 and MK3) [6]. Activated 
p38 binds to and phosphorylates MK2 to induce a 
conformational change that allows the binding and/or 
phosphorylation of the p38-MK2 complex to its substrates 
(the p38 and MK2 localisation and interaction mechanism 
has been described elsewhere [6-8]). 
 
The involvement of the p38-MK2 signalling 
cascade in regulating inflammatory responses, in particular 
the production of the pro-inflammatory cytokine tumour 
necrosis factor alpha (TNFα) has been well described in 
mammalian cells and in the spinal cord [9-11]. However, not 
much information regarding the functional involvement of 
the p38-MK2 complex is known in the brain. The expression 
of p38 and MK2 proteins has been detected in neurons and 
microglia in the brain, principally in the cortex and the 
hippocampus [12-14]. It is known that TNFα is 
predominantly synthesised and released by microglia in the 
brain [15,16]. However, the implications for the p38-MK2- 
pathway activation in the production and release of TNFα in 
the brain has not yet been well characterised. TNFα 
production and release has in recent years been shown to 
have a wide range of functions in the brain such as apoptosis, 
cell migration and proliferation [16]. In addition to these 
traditional roles for TNFα there is a growing body of 
evidence for the function of TNFα in the regulation of 
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glutamate receptor trafficking and synaptic transmission [16-
19].  
 
This review will examine the relationship between the 
reduction in glutamatergic synaptic transmission seen in 
MK2/3 double knockout (DKO) neurons that is promoted by 
reduced surface expression of α-amino-3-hydroxy-5-methyl-
4-isoxazole propionic acid receptors (AMPAR) [6] and 
correlate these findings with the possible MK2-dependent 
production of TNFα in the brain. The potential consequences 
of this MK2 regulated production of TNFα in the brain and 
the alterations in synaptic transmission that are observed in 
MK2/3 DKO animals will also be discussed. 
 
 
2. MK2/3 DKO mice have deficits in GI-mGluR-
LTD and cognitive flexibility. 
 
The recently published Eales et al., paper examined the 
changes in synaptic transmission and in cognition in the 
MK2/3 DKO mice [6]. Cultured hippocampal neurons and 
CA1 pyramidal neurons obtained from MK2/3 DKO animals 
showed altered spine morphology with an increase in the 
length of the spine neck and a decrease in spine head 
diameter compared to wild-type cells. These changes in 
spine morphology are promoted by the disruption of the p38-
MK2-cofilin cascade observed in MK2/3 DKO cells that 
regulate the depolymerisation of actin filaments [6,20]. The 
increased activation of cofilin caused a shift from 
filamentous actin to monomeric globular actin in MK2/3 
DKO mice [21]. 
 
In addition to these changes in spine morphology, 
electrophysiology recordings in cultured hippocampal 
neurons from MK2/3 DKO mice showed a reduction in 
AMPAR-mediated miniature excitatory post synaptic current 
(mEPSC) amplitude under basal conditions (Figure 1 A-D). 
This decrease in amplitude of mEPSC suggests that there are 
less AMPAR expressed at the post-synaptic density [6]. 
AMPAR are ionotropic glutamate receptors that mediate fast 
excitatory synaptic transmission, they are tetramer structures 
constructed of the four subunits, GluA1-4 [22]. In mature 
cultured hippocampal neurons AMPAR are normally 
expressed as hetrotetramers composed of dimers of the 
GluA2 and GluA1 subunits [23]. Eales et al., 2014 
demonstrated that hippocampal cultures of MK2/3 DKO 
mice displayed a reduction in both AMPAR-mediated 
mEPSC amplitude and reduced expression of the GluA1 
subunit at the cell surface. Interestingly, there was no 
reduction in the surface expression of the GluA2 subunit in 
MK2/3 DKO mouse cultures. In agreement with the 
observation in hippocampal cultures, a reduced expression of 
GluA1, but not GluA2, was observed in hippocampal lysate 
obtained from adult MK2/3 DKO mice [6]. However, the 
mechanism behind this alteration in AMPAR expression in 
MK2/3 DKO mice at the cell surface was not determined. 
Therefore further investigation is necessary to address 
whether the release of glutamate is compromised in these 
animals, as this could cause a reduction in AMPAR surface 
expression. 
 
The decrease in surface expression of the GluA1 
AMPAR subunit in MK2/3 DKO animals is significant as 
GluA2 lacking AMPAR are highly permeable to calcium 
[24, 25]. This enhanced conductance to calcium has given 
GluA1 expression interesting links to excitotoxicity and cell 
death [25,26]. Therefore decreasing GluA1 surface 
expression by the removal of MK2 protein expression could 
be neuroprotective in neurons by reducing excitatory activity 
in the brain and decreasing the amount of calcium induced 
apoptosis.  
 
Cultured hippocampal neurons obtained from MK2/3 
DKO mice showed a clear impairment in GI-mGluR-LTD 
induced by DHPG exposure (Figure 1 E). Impaired GI-
mGluR-LTD induced by either DHPG or PP-LFS was also 
observed in hippocampal slices obtained from MK2/3 DKO 
mice [6]. Importantly, GI-mGluR-LTD is dependent on the 
endocytosis of glutamate receptors, most likely GluA1-
containing AMPAR [3,6]. In agreement with impaired GI-
mGluR-LTD observed in hippocampal neurons obtained 
from MK2/3 DKO mouse, a reduction in AMPAR subunit 1 
internalization is also observed after DHPG exposure when 
compared to wild-type cells [6]. Explanations for this 
impaired mGluR LTD are that under basal conditions, 
MK2/3 DKO neurons already display a reduced amount of 
GluA1 subunits at the surface and therefore  the subsequent 
endocytosis of AMPAR by the induction of GI-mGluR-LTD 
is not sufficient to reach the threshold to trigger sufficient 
endocytosis of AMPAR to induce GI-mGluR-LTD. 
Alternatively  the knockdown of MK2 expression in 
MK2/3DKO has mimicked mGluR-LTD and therefore 
occludes the induction of mGluR-LTD. Investigating the 
relationship between MK2 and AMPAR regulation is an 
important step in understanding the synaptic deficits 
observed in MK2/3 DKO mice as well as the role of p38 and 
MK2 in GI-mGluR-LTD. In accordance with the impaired 
mGluR-LTD, the MK2/3 DKO mice displayed cognitive 
deficits specifically in hippocampal-dependent spatial 
reversal learning when their learning and memory was tested 
using a modified Barnes maze task [6]. 
 
One of the most important findings from Eales et al., is 
the observation that re-introducing MK2-WT, but not MK3-
WT, in MK2/3 DKO hippocampal neurons reversed the 
deficit in dendritic spine morphology, restored basal synaptic 
transmission and GI-mGluR-LTD to wild-type levels (Figure 
1) [6]. These findings suggest that absence of MK2 is the 
causative factor for the alternations observed in MK2/3 DKO 
mice. However the question still remains: what is the 
mechanism linking the activation of the MK2 cascade to 
reduced surface expression of GluA1 and synaptic 
transmission. Here we propose that the deficits in synaptic 
transmission seen in MK2/3 DKO animals are due to 
reduced levels of TNFα production in the brain (Figure 2).  
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3. Is TNFα production and release the missing link 
between p38-MK2 pathway activation and the 
impairment of mGluR-LTD seen in the absence of MK2? 
 
The absence of MK2 is known to reduce the amount of 
p38 protein expression and to regulate the production of 
TNFα in mammalian tissue [9-11]. In the spinal cord it has 
been shown that reduced levels of produced and released 
TNFα after injury are a direct consequence of MK2 
regulating TNFα production at a post-transcriptional level 
[10]. The mechanism by which the MK2 cascade regulates 
TNFα mRNA stability and translation after 
lipopolysaccharide (LPS) stimulation has been described 
elsewhere [9,11]. However, the mechanistic relationship 
between the MK2 cascade activation and TNFα production 
after increased activity has not yet been fully established in 
the brain. The molecular mechanism regulating the release of 
TNFα at the synapse and the activation of the signalling 
cascades at postsynaptic neurons is not yet completely 
understood. In the central nervous system, there are two 
known receptors for TNFα, TNFα receptor 1 (TNFR1) and 
TNFR2 which are expressed in hippocampal neurons [28]. 
The activation of these two diverse receptors triggers 
different signalling cascades to cause greatly different effects 
for the action of TNFα. The activation of TNFR1 triggers 
apoptotic cascades and TNFR2 activation elicits cell survival 
cascades [28,29].  
 
In the brain, TNFα concentration has been shown to 
have a role in the regulation of glutamate receptors, synaptic 
transmission, synaptic plasticity and excitotoxicity [15,17-
19,30-33]. The role of TNFα in the regulation of these 
functions is important because the correct trafficking and 
regulation of glutamate receptors is vital for normal 
development and function in the central nervous system and 
the brain. For example, exposure of neurons to a high 
concentration of 60 nM of TNFα for 15 minutes has been 
shown to cause a rapid increase in the amount of AMPAR 
GluA1 subunit expression at the cell surface in neuronal 
cultures, this was shown to be dependent on the binding of 
TNFα to the TNFR1 [19]. Conversely, exposure of 
hippocampal cultures to a recombinant soluble form of 
TNFR1, which binds to endogenous TNFα and reduces the 
amount of TNFα at synapses, resulted in decreased GluA1 
subunits expression at the cell surface and reduced basal 
synaptic strength in neurons [17,19]. This could imply that 
the reduction in surface expression of GluA1 that is observed 
in MK2/3 DKO mice [6] could be the result of a reduction in 
the amount of TNFα at the synapse released by microglia 
and/or neuron or by the effect of the activation of the p38-
MK2 cascade in neurons. The p38-MK2 cascade has been 
shown to have a mechanistic role in mGluR-LTD by 
promoting the activation of cofilin to cause actin remodeling 
as well as having a role in the removal of AMPAR in 
neurons [6] but the downstream cascades that causes 
AMPAR internalization are not clear. The MK2-dependent 
production of TNFα mediating endocytosis of GluA1 could 
provide a mechanism for the reduction of AMPAR after the 
induction mGluR-LTD.  
The developmental importance of TNFα release in the 
regulation of glutamate receptors in synaptic scaling, 
plasticity and excitotoxicity has been documented. Synaptic 
scaling maintains the delicate balance between excitatory 
and inhibitory activity, which is required for the regulation 
of homeostatic responses in the brain to maintain optimum 
neuronal activity. Exposure of neurons to TNFα disrupts 
synaptic scaling by increasing excitatory AMPAR 
expression and decreasing inhibitory γ-aminobutyric acid 
(GABAA) receptor expression [19]. There have also been 
associations of TNFα with synaptic plasticity, although LTP 
induction is normal in TNFα knockout animals [34]. 
Importantly it was observed that GI-mGluR-LTD is 
dependent on TNFα as GI-mGluR-LTD is impaired in 
TNFR1 null mice [30]. Therefore the reduction in GluA1 
expression and impaired GI-mGluR-LTD observed in the 
hippocampus when there is a reduction in TNFα, correlates 
with the reduction of GluA1 expression and impaired GI-
mGluR LTD seen in MK2/3 DKO animals. These findings 
give a strong possible link for the synaptic transmission 
alterations in MK2/3 DKO mice being regulated by the 
potential MK2 mediated reduction in TNFα.  
 
TNFα has been shown to be both neuroprotective and to 
potentiate excitotoxicity depending on its concentration at 
the synapse. Over stimulating glial cells in hippocampal 
culture increases TNFα release which induced apoptosis in 
neurons. The induction of apoptosis was TNFα mediated as 
it could be prevented by TNFα antibody application, which 
binds to TNFα and prevents its interaction with TNFα 
receptors [35]. TNFα exposure exacerbates AMPA toxicity, 
this can be demonstrated as a subtoxic dose of AMPA 
induced cell death when combined with TNFα, suggesting 
that TNFα can potentiate AMPA toxicity [29, 36]. TNFα can 
also increase neuronal susceptibility to neurotoxic insults by 
causing an increase in GluA1 receptor expression [37]. High 
concentrations of TNFα (10 ng/ml), enhanced the induction 
of neurotoxicity, whereas pre-incubation with TNFα (1 
ng/ml) for 24 hours has a neuroprotective effect on CA1 
hippocampal neurons when they are exposed to toxic levels 
of AMPA [29]. Interestingly, despite this neuroprotective 
role, there is a lack of information associating an endogenous 
reduction in TNFα release with its effect at glutamatergic 
synapse. Therefore the use of MK2 knockout (MK2 KO) 
mice could be an excellent model to study whether the 
reduction of TNFα release at excitatory synapses could have 
a neuroprotective effect. Evidence supporting this 
neuroprotective hypothesis can be demonstrated in MK2 KO 
animals, which have a significant reduction in TNFα 
production. MK2 KO mice have decreased cell death and 
increased recovery activity after spinal cord injury [10]. 
MK2 KO mice were also protected against a high bacterial 
lipopolysaccharide insult that was lethal in wild-type 
littermates [11]. In both cases the neuroprotective effect for 
the absence of MK2 was shown to be dependent on the 
reduction of cytokine production, particularly TNFα.  
 
The concentration of TNFα in the brain is high during 
development, low during adulthood and increases in aging 
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and disease states. Microglia are the primary producers of 
TNFα in the brain [13,14] and because aging has been 
associated with increased microglia activity, this is thought 
to cause an over production of TNFα in the normal aging 
brain [38,39]. In addition to this, the proliferation of 
microglia in response to stress stimuli is much higher in 
aging brains when compared to young brains, meaning 
higher quantities of microglia and TNFα [40]. This increase 
in TNFα during aging could be having numerous harmful 
neurotoxic effects and contribute to the decline in cognitive 
ability during aging. However, considerable research is 
needed to establish the role of TNFα in normal aged brain 
models. It would be interesting to investigate if an 
endogenous reduction in TNFα mediated by the absence of 
MK2 could be neuroprotective in aging and prevent 
cognitive decline. 
 
The production of TNFα has been linked to many diseases 
such as ischemia, parkinsons, and multiple sclerosis [41-43]. 
However most relevant to this review is the over production 
of TNFα in Alzheimer’s Disease, Fragile X syndrome and 
epilepsy [44-46] as these diseases have also been linked with 
altered glutamate receptor expression and excitotoxicity 
[26,47]. Alzheimer’s is a neurodegenerative disease that 
causes global cognitive impairments and is characterised by 
amyloid plaques, neurofibrillary tangles and neuronal loss 
[48]. Microglia have been shown to be over activated in 
Alzheimer’s disease which causes a rise in the release and 
synthesis of TNFα [49]. As TNFα can interact with amyloid 
precursor protein (APP) this rise in TNFα exposure has been 
shown to cause an increase in the production of Aβ [50,51] 
which is the main component of the hallmark amyloid 
plaques seen in Alzheimer’s disease brains [48]. Importantly 
the reduction of TNFα production is neuroprotective in 
Alzhiemer’s disease models. LTP in the hippocampus is 
blocked by exposure to oligomerised Aβ, this block of LTP 
can be rescued with the reduction of TNFα before exposure 
to Aβ or the removal of TNFR1 [34]. Additionally cognitive 
impairments are improved with the reduction of TNFα in 
Alzheimer’s disease model mice [51]. This neuroprotective 
reduction in TNFα is also supported by preliminary human 
clinical trials for drugs reducing the levels of TNFα in 
Alzheimer’s patients that resulted an improvement in 
cognitive deficits and a reduction in amyloid plaques and 
neurofibrillary tangles was observed [50,52]. Upstream of 
TNFα the production of MK2 is also upregulated in 
Alzheimer’s disease transgenic animals, however less 
associations have been made between MK2 and Alzheimer’s 
disease. Microglia obtained from MK2 knockout mice show 
significantly decreased TNFα production and interestingly 
there is a significant increase in cell viability on exposure to 
a neurotoxic amount of oligomerised Aβ when MK2 is 
knocked down. This neuroprotective effect of MK2 is 
thought to be mediated by a reduction in TNFα production 
levels [14]. The facilitation of mGluR-LTD by Aβ in 
Alzheimer’s disease models has been established [53] and it 
would be interesting to see if Aβ exposure was able to 
facilitate mGluR-LTD in MK2/3 DKO mice when TNFα 
levels are reduced.  
The reduction of TNFα concentration is also neuroprotective 
in epilepsy with mice lacking TNFR1 showing reduced 
susceptibility to epileptic seizures due to altered expression 
of glutamate receptors [54]. Additionally the potential 
involvement of MK2 and TNFα in Fragile X syndrome is an 
exciting possibility. Fragile X-related protein 1 (FXRP1) has 
been shown to regulate the production of TNFα at the post-
transcriptional level and when FXRP1 is knocked down in 
neuronal cultures there is an enhancement in the production 
of TNFα [46]. In the disease model for Fragile X (FMRP1 
knockout mice) there is an enhancement of mGluR-LTD 
[55], it is possible therefore that there are increased levels of 
TNFα in Fragile X disease that could be linked to the 
enhancement of mGluR-LTD seen in this disease model 
[55]. It would be interesting to further investigate both the 
role of TNFα in these disease states mentioned as well to see 
if there is an effect with the endogenous reduction of TNFα 
in these disease states. The links of TNFα to disease states 
and normal aging are particularly interesting as MK2 is 
potentially a good target for drugs, as its inhibitors have less 
side effects than drugs targeting TNFα and p38 [56].  
CONCLUSION 
In conclusion the synaptic and cognitive deficits that are 
seen in MK2/3 KO mice could be due to a reduction in the 
production and release of TNFα at the synapse. This 
reduction in TNFα at the synapse could provide a 
mechanism for the decrease in cell surface expression of 
AMPAR seen in MK2/3 DKO hippocampal neurons. This 
possible reduction in the concentration of endogenous TNFα 
production in the brain caused by the absence of MK2 could 
therefore be neuroprotective in aging and neurodegeneration 
where a fine balance in the concentration of TNFα 
production and release is needed.  
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Legend Figure 1:  
MK2 regulates synaptic transmission in hippocampal cultured neurons.  
Electrophysiology experiments recorded from hippocampal cultured neurons reproduced from Eales et al., [6]. (A) AMPAR-
dependent mEPSC traces from WT, MK2/3 DKO and MK2/3 DKO neurons expressing EGFP-tagged-MK2-WT (rescue) at 
baseline. (B) AMPAR-dependent mEPSC events recorded from WT, MK2/3 DKO and MK2/3 DKO neurons expressing MK2-
WT. (C) Mean mEPSC amplitude showing that the decrease in amplitude observed in MK2/3 DKO is reversed by re-insertion 
of MK2-WT. (D) Release probability graph, the double peaks in mEPSC amplitude distribution in DKO cells suggest that 
multiquantal release is not seen in WT or in DKO expressing MK2-WT. Shown data are from WT (n=8 cells), DKO (n=10 
cells) and DKO overexpressing MK2-WT (n=6 cells) from three to four independent preparations. (E) Graphs showing average 
time course of changes in mEPSC amplitude after DHPG (100 µM) induced mGluR LTD. Average mEPSC amplitude was 
60.6±7.4% of baseline at 45±5 min (blue trace; n=8) in WT and 95.7±7.2% (red trace; n=10) in MK2/3 DKO. Note that LTD 
was rescued in MK2/3 DKO expressing MK2-WT 66.5±7.7% (green trace; n=6). Error bars represent ± s.e.m. and *P<0.04. 
 
Legend Figure 2: 
Putative working model linking the MK2-dependent production of TNFα to AMPAR trafficking in the central nervous 
system.  
A schematic representation of the proposed mechanism by which the MK2-dependent reduction in TNF α production results in 
impaired GI-mGluR-LTD. (A) At non-stimulated dendritic spines of wild-type neurons there is a basal activity of p38, MK2 
which results in basal levels of AMPAR at the surface and basal synthesis and release of TNFα primarily by microglia at 
synapses. By contrast, in spines of non-stimulated MK2 knockout (KO) neurons, where the p38-MK2 signalling cascade is 
blocked, there is a reduced number of AMPAR receptors at the cell surface and a potential reduction in the production and 
release of TNFα at the synapse. (B) Activation of GI-mGluRs in wild-type spines induces an increase in p38 and MK2 activity 
and endocytosis of AMPAR from the cell surface, which induces mGluR-LTD. However in MK2 KO neurons, the block of the 
p38-MK2 cascade results in no change in AMPAR at the surface and impaired mGluR-LTD.  We hypothesize that this 
observation could be due to the inhibition of the MK2 downstream cascade in neurons and/or in microglia that promotes the 
reduction in TNFα synthesis and release primarily by microglia at the synapse.  
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